Biotech Values

[DewDiligence]

>> So the test - looking at improvement in vision is really not appropriate for Macugen and Lucentis. <<

Improved vision is -–and should be— a goal for wet AMD drugs. If one drug merely stabilizes already-deteriorated vision while another drug partially restores lost vision, it’s not hard to predict which one patients will prefer.